Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Journal of Geriatric Oncology|January 14, 2020
Anti-PD1 antibodies in patients aged ≥ 75 years with metastatic melanoma: A retrospective multicentre studyLaura Ridolfi, Francesco De Rosa, Elisabetta Petracci, et al.
Environmental Health : a Global Access Science Source|December 9, 2022
Per- and polyfluoroalkyl substances (PFAS) exposure in melanoma patients: a retrospective study on prognosis and histological featuresPaolo Del Fiore, Francesco Cavallin, Marcodomenico Mazza, et al.
Cancers|February 3, 2021
No Impact of NRAS Mutation on Features of Primary and Metastatic Melanoma or on Outcomes of Checkpoint Inhibitor Immunotherapy: An Italian Melanoma Intergroup (IMI) StudyMichele Guida, Nicola Bartolomeo, Pietro Quaglino, et al.
Frontiers in Oncology|March 22, 2021
Melanoma of Unknown Primary: Evaluation of the Characteristics, Treatment Strategies, Prognostic Factors in a Monocentric Retrospective StudyPaolo Del Fiore, Marco Rastrelli, Luigi Dall'Olmo, et al.
Frontiers in Oncology|May 3, 2021
Corrigendum: Melanoma of Unknown Primary: Evaluation of the Characteristics, Treatment Strategies, Prognostic Factors in a Monocentric Retrospective StudyPaolo Del Fiore, Marco Rastrelli, Luigi Dall'Olmo, et al.
Frontiers in Oncology|November 15, 2021
Corrigendum: Melanoma in Adolescents and Young Adults (AYA): Evaluation of the Characteristics, Treatment Strategies, and Prognostic Factors in a Monocentric Retrospective StudyPaolo Del Fiore, Irene Russo, Beatrice Ferrazzi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 6, 2024
Pooled Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone in Patients With Advanced MelanomaGeorgina V Long, James Larkin, Dirk Schadendorf, et al.
Frontiers in Oncology|October 4, 2021
Melanoma in Adolescents and Young Adults: Evaluation of the Characteristics, Treatment Strategies, and Prognostic Factors in a Monocentric Retrospective StudyPaolo Del Fiore, Irene Russo, Beatrice Ferrazzi, et al.
European Journal of Cancer (Oxford, England : 1990)|April 26, 2023
Discontinuation of anti-PD1 in advanced melanoma: an observational retrospective study from the Italian Melanoma IntergroupMarco Rubatto, Paolo Fava, Ignazio Stanganelli, et al.
The New England Journal of Medicine|October 22, 2025
Nivolumab for Resected Stage III or IV Melanoma at 9 YearsPaolo A Ascierto, Michele Del Vecchio, Barbara Merelli, et al.
Pageof 6